M&A · Healthcare · Buyer's industry: In Vitro & In Vivo Diagnostic Substances
Neogen Corp to acquire Delf
Announced Dec 3, 2021 · Closed Dec 3, 2021 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Neogen Corp (NEOG)
- Target
- Delf
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Dec 3, 2021
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- In Vitro & In Vivo Diagnostic Substances